Carboxylic acids and derivatives
Medchemexpress LLC Acetazolamide sodium | 1424-27-7 | 99.54% | 1 ML
Acetazolamide sodium | 1424-27-7 | 99.54% | 1 ML
CC(=O)C(O)=O)[C@@H](O)[C@H](O)[C@H](O)CO | 1g | 525017556](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502422846.PNG-250.jpg)
eMolecules 131-48-6 | N-Acetylneuraminic acid | Ambeed | MFCD23134617 | 309.271 | C11H19NO9 | 97.000 | CC(=O)N[C@H]([C@@H](O)CC(=O)C(O)=O)[C@@H](O)[C@H](O)[C@H](O)CO | 1g | 525017556
N-Acetylneuraminic acid | Ambeed | 131-48-6 | MFCD23134617 | 309.271 | C11H19NO9 | 97.000 | CC(=O)N[C@H]([C@@H](O)CC(=O)C(O)=O)[C@@H](O)[C@H](O)[C@H](O)CO | 1g | 525017556
eMolecules 849062-00-6 | 3-Ethoxy-2,6-difluorophenylboronic acid | Combi-Blocks | MFCD07369735 | 201.960 | C8H9BF2O3 | 98.000 | CCOc1ccc(F)c(B(O)O)c1F | 1g | 117523147
3-Ethoxy-2,6-difluorophenylboronic acid | Combi-Blocks | 849062-00-6 | MFCD07369735 | 201.960 | C8H9BF2O3 | 98.000 | CCOc1ccc(F)c(B(O)O)c1F | 1g | 117523147
eMolecules 78191-00-1 | N-Methoxy- N-methylacetamide | Chem-Impex | MFCD00060098 | 103.121 | C4H9NO2 | 98.000 | CON(C)C(C)=O | 100g | 386904116
N-Methoxy- N-methylacetamide | Chem-Impex | 78191-00-1 | MFCD00060098 | 103.121 | C4H9NO2 | 98.000 | CON(C)C(C)=O | 100g | 386904116
Medchemexpress LLC Lei 101 hydrochloride | 2250025-91-1 | 508.99 g/mol | 50mg
LEI-101 is a potent selective and orally bioavailable cannabinoid CB2 receptor agonist with a pEC50 of 8 for hCB2 and a pKi of less than 4 for hERG LEI-101 is 100-fold more potent in binding to CB2 receptors than to CB1 receptors[1][2]
Medchemexpress LLC 1,2-dilauroyl-sn-glycero-3-phosphoethanolamine | 59752-57-7 | MFCD00042828 | 98.0% | 579.75 | C29H58NO8P | 25 MG
1,2-Dilauroyl-sn-glycero-3-phosphoethanolamine (DLPE) is a phosphatidylethanolamine lipid bearing lauric acid (12:0) acyl chains. It is commonly used as a lipid component in the preparation of liposomes and other lipid-based formulations for research use only. The material is supplied as a white to off-white solid with high purity and specified storage conditions.
- Phosphatidylethanolamine derivative with C12:0 acyl chains.
- Suitable as a lipid component for liposome synthesis.
- High purity for research applications.
- Available in small laboratory quantities (e.g., 25 mg, 50 mg, 100 mg).
- White to off-white solid; store powder at -20°C.
![Medchemexpress LLC O=C([C@]1(CO1)CO[Si](C)(C)C(C)(C)C)[C@H](CC(C)C)NC([C@H](C)NC(CCCCCC)=O)=O | 1000313-40-5 | 99.6% | 484.74 | C25H48N2O5Si | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000229462.png-250.jpg)
Medchemexpress LLC O=C([C@]1(CO1)CO[Si](C)(C)C(C)(C)C)[C@H](CC(C)C)NC([C@H](C)NC(CCCCCC)=O)=O | 1000313-40-5 | 99.6% | 484.74 | C25H48N2O5Si | 5 MG
UK-101 is a selective immunoproteasome β1i (LMP2) inhibitor for laboratory research. It shows reported potency with an IC50 of about 104 nM and is supplied as a high-purity solid suitable for in vitro studies; recommended solvent is DMSO.
- Selective immunoproteasome β1i (LMP2) inhibitor with IC50 ≈104 nM.
- High purity (≈99.6%).
- Available in small research quantities, e.g., 5 mg.
- Recommended solvent: DMSO for dissolution.
- Powder storage: -20°C (3 years) or 4°C (2 years); solutions: -80°C (6 months).
- For research use only; not for human or clinical use.
Medchemexpress LLC VH 101, acid | 2408341-97-7 | >98.8% | C28H35FN4O6S | 50 MG
VH 101, acid | 2408341-97-7 | >98.8% | C28H35FN4O6S | 50 MG
Medchemexpress LLC Ji-101 | 900573-88-8 | MFCD26142530 | 99.8% | 466.33 | C22H20BrN5O2 | 10 MG
JI-101 is an orally available multi-kinase inhibitor that targets VEGFR2, PDGFRβ, and EphB4 and has demonstrated potent anti-cancer activity. It is provided as a white to off-white solid powder for research use and is commonly supplied in a 10 mg pack.
- Orally available multi-kinase inhibitor active against VEGFR2, PDGFRβ, and EphB4.
- High purity (99.78%).
- Molecular formula C22H20BrN5O2; molecular weight 466.33 g/mol.
- White to off-white solid, soluble in DMSO at ≥ 100 mg/mL.
- Intended for research use only; not for human administration.
Medchemexpress LLC Vnt-101 | 2894060-67-2 | 456.41 | C21H23F3N2O6 | 10 MG
VNT-101 is a small-molecule, orally active inhibitor of influenza A virus nucleoprotein (NP) oligomerization. It disrupts NP-NP protein-protein interactions to destabilize the viral ribonucleoprotein complex and has been used in vitro and in vivo to study antiviral activity across multiple influenza A subtypes.
- Disrupts nucleoprotein oligomerization to inhibit viral replication.
- Orally bioavailable small molecule suitable for in vivo studies.
- Demonstrated activity against multiple influenza A subtypes.
- Molecular weight 456.41 and molecular formula C21H23F3N2O6.
- CAS number 2894060-67-2 for substance identification.
- Supplied as a solid for research use with supporting characterization data.
Medchemexpress LLC Lauroyl-L-carnitine-d9 chloride | 2245711-25-3 | MFCD34676545 | 98.0% | 389.02 g/mol | C19H29D9ClNO4 | 5 MG
Lauroyl-L-carnitine-d9 chloride is the deuterium-labeled chloride salt of lauroyl-L-carnitine supplied for analytical and tracer applications. It is intended for use as a stable-isotope internal standard in bioanalytical, pharmacokinetic, and tracer studies where mass spectrometry differentiation is required.
- Stable isotope labeled internal standard for mass spectrometry
- Deuterated (d9) for clear mass separation from native compound
- High purity (98.0%) suitable for analytical workflows
- Chloride salt form for compatibility with common assays
- Supplied in a 5 mg quantity for small-scale analyses